IND2_STRGR
ID IND2_STRGR Reviewed; 570 AA.
AC A0A0D4BSN8;
DT 28-MAR-2018, integrated into UniProtKB/Swiss-Prot.
DT 27-MAY-2015, sequence version 1.
DT 03-AUG-2022, entry version 18.
DE RecName: Full=Beta-methylindole-3-pyruvate reductase {ECO:0000303|PubMed:25730866};
DE EC=1.1.1.397 {ECO:0000269|PubMed:25730866};
DE AltName: Full=Beta-methylindolepyruvate dehydrogenase {ECO:0000305};
GN Name=ind2 {ECO:0000303|PubMed:25730866};
OS Streptomyces griseus.
OC Bacteria; Actinobacteria; Streptomycetales; Streptomycetaceae;
OC Streptomyces.
OX NCBI_TaxID=1911;
RN [1]
RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, CATALYTIC ACTIVITY, AND
RP DISRUPTION PHENOTYPE.
RC STRAIN=ATCC 12648 {ECO:0000312|EMBL:AJT38683.1};
RX PubMed=25730866; DOI=10.1073/pnas.1419964112;
RA Du Y.L., Alkhalaf L.M., Ryan K.S.;
RT "In vitro reconstitution of indolmycin biosynthesis reveals the molecular
RT basis of oxazolinone assembly.";
RL Proc. Natl. Acad. Sci. U.S.A. 112:2717-2722(2015).
CC -!- FUNCTION: Involved in the biosynthesis of the antibiotic indolmycin, an
CC inhibitor of the bacterial tryptophan-tRNA synthetases. Catalyzes the
CC NADH-dependent reduction of beta-methylindolepyruvate to yield
CC indolmycenate. {ECO:0000269|PubMed:25730866}.
CC -!- CATALYTIC ACTIVITY:
CC Reaction=(2S,3R)-2-hydroxy-3-(indol-3-yl)butanoate + NAD(+) = (R)-3-
CC (indol-3-yl)-2-oxobutanoate + H(+) + NADH; Xref=Rhea:RHEA:10176,
CC ChEBI:CHEBI:15378, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945,
CC ChEBI:CHEBI:91180, ChEBI:CHEBI:131783; EC=1.1.1.397;
CC Evidence={ECO:0000269|PubMed:25730866};
CC -!- DISRUPTION PHENOTYPE: Cells laking this gene are unable to produce
CC indolmycenate. {ECO:0000269|PubMed:25730866}.
CC -!- SIMILARITY: Belongs to the LDH/MDH superfamily. {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; KM596502; AJT38683.1; -; Genomic_DNA.
DR AlphaFoldDB; A0A0D4BSN8; -.
DR KEGG; ag:AJT38683; -.
DR BioCyc; MetaCyc:MON-19775; -.
DR BRENDA; 1.1.1.397; 12251.
DR GO; GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW.
DR GO; GO:0017000; P:antibiotic biosynthetic process; IEA:UniProtKB-KW.
PE 1: Evidence at protein level;
KW Antibiotic biosynthesis; NAD; Oxidoreductase.
FT CHAIN 1..570
FT /note="Beta-methylindole-3-pyruvate reductase"
FT /id="PRO_0000443562"
FT ACT_SITE 306
FT /note="Proton acceptor"
FT /evidence="ECO:0000250|UniProtKB:P00344"
SQ SEQUENCE 570 AA; 62085 MW; 5AF1A4B1C1D23B8E CRC64;
MKLDDKRILI IGAGEVGTAV AEDLVNRSDP TEIIIHTSRQ QTMDMRVGHL KEMAGPRTLL
TGSWGDIFAP YELTHRSRSE INDRNVRLAL AEFFLQPSGE AQLRRTTIYE LISRHRPHIV
IDAVNSASVC TYTEDPHQTC GELLDLARGT GGPRTAEAPA ELPAVTPDIA DVATDALLSL
STPILHRYVD SLRRAMADFQ VERFIKVSTT GLGGMGYNCP YTHGSVTEFG LSDALVGKIG
SAGVLHQLLW NLHHTAGCDV RLVIPAALIG WESVRHGAYT SRGRPVALQD CSRPLPLHLD
RPLGEHAAAS SVAEPAAEDE PSAEMVHVPA GDNSTYSRAE MSLSTALGQF ESVTREEVAA
AVLDTLLGST RFDLFTAMDT ASLQSSYLAA QMRTSTLTSM RQLEKAYDRP SIVSGNLGPT
ISKDLLELHV LCTAAGSLEQ ARTMSTTVLA SSASALVRED VYLRQQALSI GLAVLLPDDQ
WLAGPRLSVP SRIDPEAKVT RADIDDWSRQ GWVDLRPARI LHWQENLRRI EQDASAGKTA
FALDDTAYDV GEVLAYHYKL TGQARRIKGL